The positive reaction in Edgewise Therapeutics' share price suggests that investors are optimistic about the offering. The capital raise could be seen as a sign of strength and potential for growth, which typically leads to a short-term increase in stock price. However, the dilutive effect of the new shares could temper gains in the longer term.